Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-01-08 @ 11:18 AM
Study NCT ID:
NCT03363503
Status:
TERMINATED
Last Update Posted:
2022-05-20
First Post:
2017-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD
Sponsor:
Neutec Ar-Ge San ve Tic A.Ş
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-17
First Submit QC Date:
None
Study First Post Date:
2017-12-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-16
Last Update Post Date:
2022-05-20
Last Update Post Date Type:
ACTUAL